GSK2340272A
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2340272A, covering 2018-02-19 to 2019-02-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) [Phase 2]